Advicenne S.A. (ALDVI.PA)
EUR 1.71
(-1.72%)
EUR 1.71
(-1.72%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.67 EUR | 40.71% |
| 2022 | -1.13 EUR | 14.39% |
| 2021 | -1.32 EUR | 21.89% |
| 2020 | -1.69 EUR | -4.97% |
| 2019 | -1.61 EUR | -177.59% |
| 2018 | -0.58 EUR | 25.64% |
| 2017 | -0.78 EUR | -25.81% |
| 2016 | -0.62 EUR | -5.08% |
| 2015 | -0.59 EUR | -90.32% |
| 2014 | -0.31 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.23 EUR | 0.0% |
| 2024 Q1 | -0.23 EUR | -53.33% |
| 2023 Q1 | -0.19 EUR | 71.21% |
| 2023 Q2 | -0.37 EUR | -94.74% |
| 2023 Q3 | -0.15 EUR | 59.46% |
| 2023 FY | - EUR | 40.71% |
| 2023 Q4 | -0.15 EUR | 0.0% |
| 2022 Q3 | -0.34 EUR | 29.17% |
| 2022 Q1 | -0.24 EUR | 45.45% |
| 2022 FY | - EUR | 14.39% |
| 2022 Q4 | -0.66 EUR | -94.12% |
| 2022 Q2 | -0.48 EUR | -100.0% |
| 2021 FY | - EUR | 21.89% |
| 2021 Q4 | -0.44 EUR | -100.0% |
| 2021 Q3 | -0.22 EUR | 75.82% |
| 2021 Q2 | -0.91 EUR | -93.62% |
| 2021 Q1 | -0.47 EUR | 42.68% |
| 2020 Q4 | -0.82 EUR | -95.24% |
| 2020 Q1 | -0.46 EUR | 48.89% |
| 2020 Q3 | -0.42 EUR | 53.33% |
| 2020 Q2 | -0.90 EUR | -95.65% |
| 2020 FY | - EUR | -4.97% |
| 2019 Q3 | -0.44 EUR | 46.99% |
| 2019 Q1 | -0.43 EUR | -688.99% |
| 2019 FY | - EUR | -177.59% |
| 2019 Q4 | -0.90 EUR | -104.55% |
| 2019 Q2 | -0.83 EUR | -93.02% |
| 2018 Q4 | -0.05 EUR | 0.0% |
| 2018 Q3 | -0.05 EUR | 77.29% |
| 2018 Q1 | -0.24 EUR | 14.29% |
| 2018 Q2 | -0.24 EUR | 0.0% |
| 2018 FY | - EUR | 25.64% |
| 2017 Q4 | -0.28 EUR | 0.0% |
| 2017 Q2 | -0.22 EUR | 0.0% |
| 2017 Q1 | -0.22 EUR | 0.0% |
| 2017 FY | - EUR | -25.81% |
| 2017 Q3 | -0.28 EUR | -27.27% |
| 2016 FY | - EUR | -5.08% |
| 2016 Q1 | -0.24 EUR | 0.0% |
| 2016 Q2 | -0.24 EUR | 0.0% |
| 2016 Q3 | -0.22 EUR | 8.33% |
| 2016 Q4 | -0.22 EUR | 0.0% |
| 2015 FY | - EUR | -90.32% |
| 2014 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -458.333% |
| ABIVAX Société Anonyme | -3.43 EUR | 80.466% |
| Adocia SA | -1.91 EUR | 64.921% |
| Aelis Farma SA | -0.39 EUR | -71.795% |
| Biophytis S.A. | -12.55 EUR | 94.661% |
| genOway Société anonyme | 0.17 EUR | 494.118% |
| IntegraGen SA | -0.03 EUR | -2486.873% |
| Medesis Pharma S.A. | -0.80 EUR | 16.25% |
| Neovacs S.A. | -0.00 EUR | -26700.0% |
| NFL Biosciences SA | -0.46 EUR | -45.652% |
| Plant Advanced Technologies SA | 0.07 EUR | 1057.143% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -636.264% |
| Sensorion SA | -0.17 EUR | -294.118% |
| Theranexus Société Anonyme | -0.88 EUR | 23.864% |
| TME Pharma N.V. | -1.34 EUR | 50.0% |
| Valbiotis SA | -0.59 EUR | -13.559% |
| TheraVet SA | -0.49 EUR | -36.735% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -346.667% |
| DBV Technologies S.A. | -0.71 EUR | 5.634% |
| Genfit S.A. | -0.58 EUR | -15.517% |
| GeNeuro SA | -0.59 EUR | -13.559% |
| Innate Pharma S.A. | -0.09 EUR | -612.009% |
| Inventiva S.A. | -2.43 EUR | 72.428% |
| MaaT Pharma SA | -1.73 EUR | 61.272% |
| MedinCell S.A. | -0.88 EUR | 23.864% |
| Nanobiotix S.A. | -1.08 EUR | 37.963% |
| OSE Immunotherapeutics SA | -1.18 EUR | 43.22% |
| Poxel S.A. | -0.91 EUR | 26.374% |
| GenSight Biologics S.A. | -0.54 EUR | -24.074% |
| Transgene SA | -0.22 EUR | -204.545% |
| Valneva SE | -0.73 EUR | 8.219% |